b2i-digital-nanomix-logo-banner

Nanōmix Corp.

Nanōmix is a leader in decentralized testing and a participant in the large, fast-growing Point of Care (POC) diagnostics market. Their market-ready Critical Infection Panel is the only portable, rapid PCT assay and allows for obtaining critical information more quickly, leading to faster clinical decision-making.

OTCQB: NNMX
IR Website: https://ir.nano.com/
Headquarters: San Leandro, CA

Nanōmix has invested heavily into IP with all technology developed and wholly owned by the company, including 23 issued and pending patents. As a result they are moving towards a robust and connected future of one instrument with lab quality results for many different tests.

TALK TO MANAGEMENT

The Nanōmix management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.

Summary

Press Releases

Investor Presentation

Stock Chart (Intraday)

Stock Chart (Historical)

Stock Detail

Video: The Nanōmix Vision

Video: An Introduction to Nanōmix with Board Member and ex-CEO David Ludvigson

Video: Diving Deeper Into The Company Itself

Disrupting the Place and Time of Quality Diagnostics, Better Outcomes

Accessibility to the Quality of Our Technology

Platform Technology, Designed for Rapid Menu Expansion

Addressing Major Market Needs

Expertise Matters

The Point-of-Care (PoC) Industry

Nanōmix's Intellectual Property and Regulatory Clearance

Financials

SEC Filings

Management Overview

Risks & Disclosures

nanomix-logo_white

The Nanomix management and investor relations team is available to talk to current and potential investors. They're happy to answer your questions and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.

• Directly hear the Nanomix story
• Ask your questions
• Submit the form below and someone will get in touch with you as soon as possible

Note: Company management or its representative can only discuss and disclose information that is already available in the public domain. They will do their best to clarify such information to the extent permitted by securities law and industry regulations.